Title : Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene.

Pub. Date : 2018 Nov

PMID : 30333878






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Furthermore, in the presence of metformin, inhibitors of the p38 MAPK and JNK signaling pathway at different concentrations did not affect the levels of Nrf2, but inhibitors of the Akt and ERK1/2 pathway at different doses reduced the expression of Nrf2. Metformin mitogen-activated protein kinase 3 Homo sapiens
2 In addition, inhibitors of p38 MAPK and JNK did not affect the effect of metformin on Nrf2, while inhibitors of Akt and ERK1/2 dose-dependently enhanced the inhibitory effects of metformin in A549 cells. Metformin mitogen-activated protein kinase 3 Homo sapiens
3 In addition, inhibitors of p38 MAPK and JNK did not affect the effect of metformin on Nrf2, while inhibitors of Akt and ERK1/2 dose-dependently enhanced the inhibitory effects of metformin in A549 cells. Metformin mitogen-activated protein kinase 3 Homo sapiens
4 In conclusion, metformin inhibits the phosphoinositide-3 kinase/Akt and ERK1/2 signaling pathways in A549 cells to reduce the expression of Nrf2, GSTA1 and ABCC1. Metformin mitogen-activated protein kinase 3 Homo sapiens